Study to Examine the Effects of MultiStem in Ischemic Stroke
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 134 participants.
Also called NCT01436487
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 134 participants
- Sponsor
- Registry
-
NCT01436487
-
- Other papers using this trial's data
- Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01436487. Randomized; quadruple masking; primary purpose treatment. Start 2011-10 (registry gives no type); primary completion 2015-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study to Examine the Effects of MultiStem in Ischemic Stroke
- Condition
- Ischemic Stroke
- Intervention (Biological)
- MultiStem
- Intervention (Biological)
- Placebo
- Lead sponsor
- Healios K.K.
- Collaborator
- Medpace, Inc.
Record details
- Record id
cardio:ct-nct01436487- Content hash
7063f8d04b441daa8d46c42eca409eea6bc27e92eaf78a26d7f80742e32f1c62